Exchange-traded funds focused on consumer staples often serve as a defensive anchor in portfolios, and IYK and VDC are two of the more prominent options. The iShares U.S. Consumer Staples ETF and the Vanguard Consumer Staples ETF both aim to capture U.S. producers and retailers of food, beverages, tobacco, and household goods. Their underlying indexes, however, diverge in ways that affect sector exposure, fees, and overall risk. From what I see, understanding these structural elements matters more than chasing short-term price swings when deciding how to position within this defensive corner of the market.
IYK tracks the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, a market-cap-weighted benchmark of U.S. consumer staples firms. Launched in 2000, the fund holds about 54 stocks and carries a 0.38% expense ratio. Top holdings include PG, KO, PM, PEP, and CVS. One notable feature is that its index treats certain healthcare distributors as consumer staples, resulting in roughly 85% consumer defensive exposure, 11% healthcare, and a small basic-materials allocation. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. This setup gives IYK broader but less pure staples exposure.
VDC follows the MSCI US Investable Market Consumer Staples 25/50 Index, covering large-, mid-, and small-cap U.S. consumer staples companies. Launched in 2004, it holds approximately 104 stocks with a 0.09% expense ratio. Its largest positions feature WMT, COST, PG, KO, and PM. In contrast to IYK, VDC stays nearly pure consumer defensive at about 98% of assets, with only minor allocations elsewhere. This broader, lower-cost construction and emphasis on mega-cap retailers set its positioning apart.
Consumer staples have drawn renewed interest lately as investors look for lower-volatility holdings amid changing rate expectations and uneven growth. These defensive names tend to hold up better when spending slows, though they can trail in strong risk-on periods. Pricing power in food and beverages, steady tobacco cash flows, and retailer cost pressures stand out as key themes. Regulatory questions around pricing and trade-down behavior remain risks. Both funds feel these influences, yet their differing classifications mean healthcare exposure in IYK and retailer concentration in VDC can respond to distinct signals.
Recently, VDC has drawn support from strength in mega-cap retailers and its lower fee, while IYK’s results have faced some headwinds from its higher expense ratio and healthcare-distribution holdings that move more cyclically. Over longer periods both deliver defensive, lower-beta characteristics, but VDC’s wider diversification and larger size often translate into tighter trading and better liquidity. Sector rotation, earnings from top holdings, and rate expectations drive relative moves, with VDC’s retailer tilt sometimes magnifying gains when staples gain favor.
When comparing these ETFs, I occasionally turn to Tickeron’s AI tools to cross-check sector trends and holdings data. One short sentence sums it up: the platform helps surface patterns that might otherwise take longer to identify manually.
Based on the structural details, Tickeron’s AI would likely lean toward VDC over IYK right now. VDC offers a meaningfully lower expense ratio (0.09% versus 0.38%), wider diversification across roughly 104 holdings, stronger liquidity, and a more consistent consumer-defensive profile. IYK’s healthcare tilt adds some breadth but also brings in more cyclical risk and a higher ongoing cost. While both provide defensive exposure, VDC’s cost efficiency, scale, and purer sector alignment give it a probabilistic edge for investors considering relative positioning in consumer staples. This view remains analytical and is not a personalized recommendation.
In my own work I have found Tickeron’s AI Screener helpful for quickly filtering ETFs and stocks by industry, technical signals, and performance metrics. The tool lets users scan thousands of names with customizable criteria and can highlight ideas more efficiently than manual methods. It has become one part of how I build a data-driven view of sector opportunities like the one discussed here.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day RSI Oscillator for IYK moved out of overbought territory on October 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 instances where the indicator moved out of the overbought zone. In 31 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a move down at 82%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IYK as a result. In 61 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for IYK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 30 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
IYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for IYK crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 72%.
Following a +1.76% 3-day Advance, the price is estimated to grow further. Considering data from situations where IYK advanced for three days, in 266 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 229 of 305 cases where IYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows